The European Commission adopted two legal acts aimed at improving patient safety in the EU through good manufacturing practices (GMP) that ensure the highest quality of medicines for human use.
The first act is an implementing directive that sets out principles and guidelines of GMP in medicines where the manufacture or import is subject to a manufacturing authorisation: see Article 40 of the Community code Directive (2001/83/EC).
The second act is a delegated regulation that sets out GMP for investigational medicinal products, as required by the Clinical Trials Regulation (536/2014/EU), and detailed arrangements for inspections. This legal act ensures the highest quality of medicinal products used in clinical trials and prepares the smooth entry into force of this Regulation.
To read more about this on the europa.eu website: http://ec.europa.eu/newsroom/sante/newsletter-specific-archive-issue.cfm?newsletter_service_id=327&newsletter_issue_id=5153
The German government’s Federal Ministry of Education and Research (BMBF) is dedicating up to EUR 500 million in the coming decade to support the G20’s international research initiative devoted to fighting antimicrobial resistance (AMR). The initiative was announced in the G20 leaders’ final declaration at the end of the G20 summit in July. The BMBF’s funding pledge came shortly afterwards.
Germany has played a decisive role in getting the AMR initiative up and running during its G20 presidency. Ahead of the summit in Hamburg, the country organised and held the first-ever meeting solely for G20 health ministers.
To read more about this initiative on the German Federal Ministry for Economic Affairs and Energy website: http://www.exportinitiative-gesundheitswirtschaft.de/EIG/Redaktion/EN/Kurzmeldungen/News/2017/2017-08-15-germany-promotes-g20-initiative-against-antimicrobial-resistance.html
European women’s probability of developing breast cancer over a lifetime is approximately 1 in 8*. A woman’s individual risk of breast cancer may be higher or lower than this average, depending on a number of factors, including age, family history, reproductive history (such as menstrual and childbearing history), race/ethnicity, and others.
The ECIBC is developing recommendations for breast cancer screening and diagnosis. Each recommendation is specifically tailored to the needs of citizens and patients, health professionals, and policy makers. All recommendations are based on the female population at ‘average’ and ‘below average’ risk of developing breast cancer.
To read more about this initiative on the Europa.eu site: http://ecibc.jrc.ec.europa.eu/recommendations/
Since 2015, hundreds of thousands of migrants and refugees have entered Europe, either escaping conflict in their country or in search of better economic prospects.Most migrants are healthy when they arrive in the EU, but they can be affected by conditions and factors prior to their travel or during their journey. They may be suffering from physical exhaustion, extreme distress, dehydration or cold. These challenges, combined with other issues, such as inadequate living conditions or unhealthy lifestyles, can seriously impact their physical and mental health. If they were already dealing with chronic diseases, their health may have further deteriorated.
No person entering the EU should be left without access to basic healthcare, and no EU country can or should be left alone to manage the public health dimension of such an unprecedented crisis.
To read more about improving health of refugees and migrants at europa.eu: http://ec.europa.eu/chafea/news/news523.html
In a recent study, screening rates for hepatitis C virus (HCV) infection among baby boomers increased fivefold in the year following implementation of an electronic health record (EHR)-based prompt for primary care physicians. The prompt also led to dramatic increases in follow-up specialised care for infected patients, according to the Hepatology study.
To read more: Electronic Health Record Alert Improves HCV Screening and Treatment
According to a new UN report world hunger is once again on the rise, driven by conflict and climate change. 815 million people are now hungry and millions of children are at risk from malnutrition.
After steadily declining for over a decade, global hunger is on the rise again, affecting 11 per cent of the global population. At the same time, multiple forms of malnutrition are threatening the health of millions worldwide. The increase – 38 million more people than the previous year – is largely due to the proliferation of violent conflicts and climate-related shocks, according to The State of Food Security and Nutrition in the World 2017.
To read more on the WHO website: http://who.int/mediacentre/news/releases/2017/world-hunger-report/en/
An analysis of the antibacterial clinical development pipeline, including tuberculosis, launched by WHO shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.
The report found very few potential treatment options for those antibiotic-resistant infections identified by WHO as posing the greatest threat to health, including drug-resistant tuberculosis which kills around 250 000 people each year.
Source: WHO | The world is running out of antibiotics, WHO report confirms
The World Health Organization (WHO) has updated its fact sheet on suicide. Key facts include:
- Close to 800 000 people die due to suicide every year.
- For every suicide there are many more people who attempt suicide every year. A prior suicide attempt is the single most important risk factor for suicide in the general population.
- Suicide is the second leading cause of death among 15–29-year-olds.
- 78% of global suicides occur in low- and middle-income countries.
Ingestion of pesticide, hanging and firearms are among the most common methods of suicide globally.
Read more about this on the WHO website: http://www.who.int/mediacentre/factsheets/fs398/en/
The World Health Organization (WHO) has updated its fact sheet on falls. Key facts include:
- Falls are the second leading cause of accidental or unintentional injury deaths worldwide.
- Each year an estimated 646 000 individuals die from falls globally of which over 80% are in low- and middle-income countries.
- Adults older than 65 years of age suffer the greatest number of fatal falls.
- 37.3 million falls that are severe enough to require medical attention occur each year.
- Prevention strategies should emphasize education, training, creating safer environments, prioritizing fall-related research and establishing effective policies to reduce risk.
To read more on the WHO website: http://www.who.int/mediacentre/factsheets/fs344/en/
Unhealthy diet is the biggest risk factor for disability adjusted life years lost (DALYs) in the EU, principally through diabetes, cancer, and cardiovascular diseases, with tobacco and alcohol also contributing significantly to the growing burden of chronic diseases on health services.
Of course, this is far from coincidental. The private sector has a number of strategies and approaches that it employs “to promote products and choices that are detrimental to health”. They include marketing, which enhances the desirability and acceptability of products. Marketing in all its forms is key to unhealthy commodities’ acceptability, and crucially, their appeal.
To read more about these links on the epha.org site: https://epha.org/explaining-the-links-between-commercial-determinants-of-health-and-chronic-diseases/